Abstract: A population comparison system, method and a computer program product. A stored list of population members, e.g., hydrocarbon reservoirs, includes parameters for corresponding known characteristics and analogous members for each member. A new population member input receives new member descriptions including parameters for each respective new member. A parameter extraction system automatically extracts an estimated value for each missing key parameter, providing a supplemented description. An analogous member selector automatically selects a subset of listed population members as analogous members for each new population member responsive to the supplemented description. The analogous members serve as a basis for uncertainty characterization from the joint parameter distribution and univariate distributions for each parameter.

Abstract: A population comparison system, method and a computer program product therefor. A stored list of population members, e.g., hydrocarbon reservoirs, includes parameters for corresponding known characteristics and analogous members for each member. A new population member input receives new member descriptions including parameters for each respective new member. A parameter extraction system automatically extracts an estimated value for each missing key parameter, providing a supplemented description. An analogous member selector automatically selects a subset of listed population members as analogous members for each new population member responsive to the supplemented description.

Abstract: The new derivatives of pyroglutaminic acid have the formula (I) wherein R.sup.1, R.sup.2 and R.sup.3 are H or COR.sup.4, R.sup.4 being lower alkyl or aryl, A.sup.- is Cl.sup.-, CH.sub.3 COO.sup.- and OH.sup.- and the ondulated line means that the substituent occupies any of the possible spatial positions. The process comprises the reaction of serine with pyridine and acetic anhydrid. These compounds may be applied in immunology as modifiers of the biological immune response, in the "integral" treatment of cancer and prevention or treatment of serious systemic infections in "high risk" patients suffering of chronical diseases and secondary immunodeficiency (cancer, AIDS, Diabetes Mellitus), or primary immunodeficiency (syndromes of DiGeorge, Down).